gershon
New_Member
original research here..... just a matter of time before it starts showing up I suppose....
NK2R control of energy expenditure and feeding to treat metabolic diseases - Nature
In mouse and nonhuman primate models, treatment with selective, long-acting neurokinin 2 receptor agonists aids weight loss by suppressing appetite and increasing energy expenditure, as well as by increasing insulin sensitivity.
www.nature.com